for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

SurModics, Inc.

SRDX.OQ

Latest Trade

47.06USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

42.47

 - 

61.35

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
47.06
Open
--
Volume
--
3M AVG Volume
1.11
Today's High
--
Today's Low
--
52 Week High
61.35
52 Week Low
42.47
Shares Out (MIL)
13.98
Market Cap (MIL)
657.68
Forward P/E
-32.01
Dividend (Yield %)
--

Next Event

Surmodics Inc at Sidoti & Company Winter Small Cap Conference (Virtual)

Latest Developments

More

Surmodics Reports Fourth Quarter Fiscal 2021 Results

Surmodics Reports Third Quarter Fiscal 2021 Results And Updates Fiscal 2021 Revenue And EPS Guidance

Surmodics Reports Second Quarter Fiscal 2021 Results And Issues Fiscal 2021 Revenue And EPS Guidance

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About SurModics, Inc.

Surmodics, Inc. is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.

Industry

Medical Equipment & Supplies

Contact Info

9924 W 74th St

EDEN PRAIRIE, MN

55344-3523

United States

+1.952.5007000

http://www.surmodics.com/

Executive Leadership

Susan E. Knight

Non-Executive Independent Chairman of the Board

Gary R. Maharaj

President, Chief Executive Officer, Director

Timothy J. Arens

Chief Financial Officer, Senior Vice President - Finance and Information Technology

Teri L.W. Sides

Senior Vice President - Product Development, Chief Marketing Officer

Gordon S. Weber

Senior Vice President - Legal, General Counsel, Secretary

Key Stats

1.50 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019

0.1K

2020

0.1K

2021

0.1K

2022(E)

0.1K
EPS (USD)

2019

0.720

2020

0.130

2021

0.370

2022(E)

-1.470
Price To Earnings (TTM)
156.89
Price To Sales (TTM)
6.26
Price To Book (MRQ)
4.67
Price To Cash Flow (TTM)
53.67
Total Debt To Equity (MRQ)
7.14
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
2.69
Return on Equity (TTM)
2.33

Latest News

Latest News

BRIEF-Surmodics Files For Mixed Shelf Of Up To $200 Million

* SURMODICS INC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING Source text: (https://bit.ly/3giTIbk) Further company coverage:

BRIEF-Surmodics Reports Q2 Fiscal 2020 Results

* SURMODICS REPORTS SECOND QUARTER FISCAL 2020 RESULTS AND PROVIDES COVID-19 PANDEMIC UPDATE

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up